XOMAO News and Press, XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock From 05/05/22

Earned a $2 million milestone from Rezolute as it dosed the final patient in a Phase 2 open-label study of RZ358 in patients with congenital hyperinsulinism in early 2022.  Rezolute has announced its intention to move RZ358 into Phase 3 clinical development. Roche’s ...

The following slide deck was published by XOMA Corporation in conjunction with this event. For further details see: XOMA (XOMA) Investor Presentation - Slideshow

Investing in the biotech industry is an art, not a science. While the potential for gains from groundbreaking therapies exists, the majority fail. By utilizing statistics, careful selection, and net present value calculations, it is quite easy to find a basket that fulfills your p...

XOMA Corp - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th (NASDAQ:XOMAO) declares $0.5234/share quarterly dividend, in line with previous. Forward yield 8.07% Payable Jan. 18; for shareholders of record Jan. 4; ex-div Jan. 3. See XOMAO Dividend Scorecard, Yield Chart, & Dividend Growth. ...

Half of my retirement savings is invested in two sectors. It's important to match your investment allocations to what will meet your goals and needs. Income investing provides extremely high levels of flexibility. For further details see: I Put Half Of My Retirement Savi...

XOMA Corp - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th (XOMAO) declares $0.5583/share quarterly dividend.Forward yield 9.06%Payable July 15; for shareholders of record July 2; ex-div July 1.See XOMAO Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: XOMA...

EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferr...